Chevy Chase Trust Holdings LLC Has $5.57 Million Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Chevy Chase Trust Holdings LLC reduced its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 1.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 73,765 shares of the company’s stock after selling 982 shares during the period. Chevy Chase Trust Holdings LLC’s holdings in Henry Schein were worth $5,571,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the stock. McGlone Suttner Wealth Management Inc. bought a new stake in shares of Henry Schein during the 4th quarter worth about $39,000. Neo Ivy Capital Management bought a new stake in shares of Henry Schein during the third quarter worth approximately $46,000. Mather Group LLC. acquired a new position in shares of Henry Schein in the first quarter valued at approximately $97,000. Palisade Asset Management LLC bought a new position in shares of Henry Schein during the first quarter worth approximately $113,000. Finally, Benjamin F. Edwards & Company Inc. lifted its holdings in Henry Schein by 37.8% during the 4th quarter. Benjamin F. Edwards & Company Inc. now owns 1,516 shares of the company’s stock worth $114,000 after purchasing an additional 416 shares during the last quarter. 96.62% of the stock is owned by institutional investors.

Henry Schein Price Performance

Shares of Henry Schein stock traded up $0.80 during trading on Thursday, reaching $64.99. 66,601 shares of the company’s stock were exchanged, compared to its average volume of 1,064,458. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.02 and a current ratio of 1.75. Henry Schein, Inc. has a 1-year low of $60.01 and a 1-year high of $82.63. The company has a market cap of $8.32 billion, a P/E ratio of 21.99, a PEG ratio of 1.60 and a beta of 0.87. The firm’s 50-day moving average price is $68.78 and its 200 day moving average price is $72.36.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, May 7th. The company reported $1.10 EPS for the quarter, topping the consensus estimate of $1.01 by $0.09. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. The firm had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.21 billion. During the same quarter in the previous year, the firm earned $1.21 earnings per share. The business’s quarterly revenue was up 3.7% on a year-over-year basis. As a group, research analysts anticipate that Henry Schein, Inc. will post 5.16 earnings per share for the current year.

Analyst Upgrades and Downgrades

HSIC has been the topic of several recent research reports. UBS Group lowered their price objective on Henry Schein from $82.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 8th. Barrington Research reiterated an “outperform” rating and issued a $92.00 price objective on shares of Henry Schein in a research note on Friday, July 5th. Evercore ISI decreased their target price on shares of Henry Schein from $75.00 to $72.00 and set an “in-line” rating on the stock in a research report on Tuesday. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $86.00 target price on shares of Henry Schein in a report on Friday, June 21st. One investment analyst has rated the stock with a sell rating, six have given a hold rating and five have issued a buy rating to the stock. According to MarketBeat, Henry Schein currently has a consensus rating of “Hold” and a consensus target price of $80.73.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.